Target intelligence / Profile preview

Immunological antigen (Ag)

Target
Ag
Molecular classification
Other
01

Overview

Immunological antigens are diverse molecules, primarily proteins or polysaccharides, that are recognized by the adaptive immune system to elicit a specific immune response (NIH National Cancer Institute). They function as the primary recognition elements for antibodies and T-cell receptors, facilitating the identification of foreign pathogens such as viruses and bacteria, as well as abnormal host cells like those found in cancer (StatPearls, 2023). In clinical practice, antigens are the foundational components of vaccines, which introduce specific epitopes to prime the immune system for future encounters with pathogens (Nature Reviews Drug Discovery, 2020). Furthermore, specific antigens serve as the targets for monoclonal antibody therapies and chimeric antigen receptor (CAR) T-cell therapies, which are engineered to bind to surface-expressed markers on diseased cells. However, the broad nature of antigens also encompasses allergens and autoantigens, which can trigger harmful hypersensitivity or autoimmune reactions (Janeway's Immunobiology, 2016). Consequently, while they are essential for protective immunity, their therapeutic manipulation requires precise targeting to avoid off-target effects and systemic toxicity.

Other names
AntigenImmunogenAllergenNeoantigenAutoantigenEpitope
02

Mechanism of action

Antigens act as the molecular triggers for the adaptive immune system; they are recognized by B-cell receptors (BCRs) or processed into peptides and presented by Major Histocompatibility Complex (MHC) molecules to T-cell receptors (TCRs), leading to lymphocyte activation and clonal expansion (Janeway's Immunobiology, 2016; StatPearls, 2023).

03

Biological functions

Immune responseAntigen presentationAdaptive immunityLymphocyte activationHost defense
04

Disease associations

InfectionCancerAutoimmune diseaseAllergyInflammation
05

Safety considerations

AnaphylaxisCytokine release syndrome (CRS)Autoimmunity due to molecular mimicryImmune evasion through antigenic driftOff-target toxicity
06

Interacting drugs

Vaccines

4 more in the full profile.

07

Biomarkers

Antibody titersAntigen-specific T-cell frequencySoluble antigen levels (e.g., PSA, CEA)Circulating tumor DNA (ctDNA)

Beyond the preview

Go deeper on Immunological antigen (Ag).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunological antigen (Ag).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call